Renascience, Inc. engages in the development and sale of pharmaceuticals. It deals with the research and development of new medical solutions utilizing various modalities such as pharmaceuticals, medical devices, and artificial intelligence to solve problems in the medical field. The company was founded on February 15, 2000 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company